PremiumThe FlyParagon 28 downgraded to Hold from Buy at Needham BofA moves to No Rating on Paragon 28 after Zimmer Biomet deal PremiumThe FlyParagon 28 falls -9.5% Paragon 28 sees Q4 revenue $71.5M-$71.8M , consensus $69.62M Paragon 28 Expands Board with New Independent Director PremiumThe FlyParagon 28 rises 21.3% Paragon 28 price target lowered to $15 from $17 at Canaccord Paragon 28 Increases Revenue Guidance Amid Growth 
